PTPA and Global developmental delay: Although PP2A affected individuals exhibit common clinical features, including hypotonia, developmental delay (DD) (motoric skills, speech), intellectual disability (ID), differences in brain size, autism (ASD), and seizures, they also show a broad heterogeneity in the severity of their presentation—within individuals affected in different PP2A genes, as well as within individuals affected in the same PP2A gene.